Picarro Inc. has launched the PI2124 Analyzer, an advanced solution for monitoring vaporized hydrogen peroxide (VHP) in pharmaceutical and regulated manufacturing settings. The new analyzer can continuously measure VHP at concentrations as low as 3 parts per billion (ppb). It incorporates software enhancements designed to improve data integrity, audit readiness, and operational efficiency, thereby strengthening compliance support and daily workflows. VHP is crucial for decontamination in pharmaceutical and medical device manufacturing, and the PI2124 aims to provide precise, real-time measurements while streamlining data recording, review, and documentation processes. This launch allows customers to benefit from new software capabilities without disrupting existing validated hardware installations.
The launch of the PI2124 Analyzer addresses critical needs for enhanced VHP monitoring and compliance in the highly regulated pharmaceutical industry. Its ability to detect low VHP levels and improve data integrity directly supports stricter regulatory requirements and operational efficiency, potentially reducing validation costs and time-to-market for drug manufacturers.
Picarro launched the PI2124 Analyzer for VHP monitoring in pharmaceutical manufacturing.
The analyzer measures VHP at levels as low as 3 ppb.
Software enhancements improve data integrity, audit readiness, and operational efficiency.
This product launch is particularly relevant for pharmaceutical and medical device manufacturers in regions with stringent regulatory oversight, such as North America and Europe, where compliance and data integrity are paramount.
Picarro launched the PI2124 Analyzer for VHP monitoring in pharmaceutical manufacturing.
The analyzer measures VHP at levels as low as 3 ppb.
Sign in to save notes on signals.
Sign In